Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments

Author(s):
Coppo, R.; Troyanov, S.; Bellur, S.; Cattran, D.; Cook, H.T.; Feehally, J.; Roberts, I.S.D.; Morando, L.; Camilla, R.; Tesar, V.; Lunberg, S.; Gesualdo, L.; Emma, F.; Rollino, C.; Amore, A.; Praga, M.; Feriozzi, S.; Segoloni, G.; Pani, A.; Cancarini, G.; Durlik, M.; Moggia, E.; Mazzucco, G.; Giannakakis, C.; Honsova, E.; Sundelin, B.B.; Palma, A.M. di; Ferrario, F.; Gutierrez, E.; Asunis, A.M.; Barratt, J.; Tardanico, R.; Perkowska-Ptasinska, A.; VALIGA Study ERA-EDTA
Published
2014
Publication type
Article / Letter to editor
glomerular diseasesIgA nephropathyprogression of chronic renal failureproteinuriarenal pathologyrisk factors
Date issued
2014-10-31
Language
English
Is part of
Kidney International (2014), Vol. 86, no. 4, p. 828-836
hdl
1887/108085
doi
10.1038/ki.2014.63